-
公开(公告)号:EP2194976A4
公开(公告)日:2012-12-26
申请号:EP08782880
申请日:2008-08-04
申请人: BIOTRON LTD
IPC分类号: A61K31/155 , A61K31/167 , A61K31/18 , A61K31/341 , A61K31/36 , A61K31/381 , A61K31/415 , A61K31/435 , A61K31/7056 , A61K31/7064 , A61K31/7068 , A61K38/21 , A61K45/06 , A61P31/14
CPC分类号: C07C279/22 , A61K31/155 , A61K31/166 , A61K31/167 , A61K31/18 , A61K31/341 , A61K31/36 , A61K31/381 , A61K31/415 , A61K31/435 , A61K31/4418 , A61K31/7056 , A61K31/7064 , A61K31/7068 , A61K31/7076 , A61K38/21 , A61K38/212 , A61K45/06 , C07C311/08 , C07D213/69 , C07D231/12 , C07D307/54 , C07D333/24 , A61K2300/00
摘要: The present invention relates to novel compositions having anti-viral activity and in particular it relates to synergistic compositions active against Hepatitis C virus (HCV). The invention also relates to methods for retarding, reducing or otherwise inhibiting HCV growth and/or functional activity.